JOVANA
Library Glossary Getting Started Three Levels Fields How it works Mission
Join the mission
All guides

Half-Life, AUC & the Concentration–Time Curve

Plot drug concentration in blood against time and you get the single most informative picture in PK. From its peak, its area, and its decay you read Cmax, Tmax, AUC, half-life, and total exposure — the numbers that link dose to effect.

Reading the curve

Give a single oral dose and sample the blood over time, and the plasma concentration traces a characteristic arc. It climbs as absorption outpaces elimination, reaches a peak called Cmax at a time called Tmax, then falls as elimination takes over. Three features of this curve carry almost everything you need to know about a drug's exposure.

  1. [[cmax|Cmax]] — the highest concentration reached. Often relevant to side effects and toxicity: a sharp spike can cross a danger threshold.
  2. [[tmax|Tmax]] — the time at which Cmax occurs. A short Tmax means fast absorption (rapid onset); a long Tmax means a slow, gentle rise.
  3. [[med-auc|AUC]] — the area under the concentration–time curve. This is *total exposure*: how much drug, integrated over how long. AUC is the master measure tying dose to effect.

Half-life: the decay clock

Half-life (t½) is the time for the plasma concentration to fall by half during the elimination phase. For most drugs, elimination is *first-order* — a constant *fraction* is removed per unit time — so the decay is exponential and the half-life is constant whatever the starting level. Half-life is governed by the elimination rate constant and, crucially, it is derived from the two parameters you met last guide.

First-order elimination — the master relationship:

  t½  =  0.693 × Vd / CL          (0.693 = ln 2)

So half-life RISES with volume of distribution
and FALLS with clearance.

After each half-life, the amount remaining halves:
  1 t½ ->  50% left
  2 t½ ->  25% left
  3 t½ ->  12.5% left
  4 t½ ->  ~6% left
  5 t½ ->  ~3% left   (effectively 'gone')

Rule of thumb: a drug is essentially cleared after
about 4–5 half-lives.

And exposure ties straight back to dose and clearance:

  AUC  =  (F × Dose) / CL
Half-life comes from Vd and CL; AUC comes from dose, bioavailability, and CL.

From curve to clinical decisions

The shape of the curve translates directly into how a drug is used. A short half-life may demand dosing several times a day — inconvenient and easy to miss; a long half-life supports once-daily or even weekly dosing. AUC is the link between the molecular world and the patient: in PK/PD modeling chemists connect exposure (PK) to effect (PD) to ask the central question — *does the concentration we can achieve stay above what the target needs, without climbing into toxicity?*